Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
regenHU is a Swiss medtech and life science tools company focused on 3D bioprinting instruments and software for research and translational applications. The company develops configurable bioprinter systems and workflow software used in tissue engineering, regenerative medicine, complex 3D cellular models for drug discovery, human skin models, and personalized oral dose formulation. Its main commercial platform includes the R-GEN series bioprinters and SHAPER design and bioprinting management software. Rather than developing its own therapeutic drug pipeline, regenHU primarily sells enabling technologies and provides application support to academic labs, biotech companies, and pharmaceutical companies. The company appears to operate as a private, active business headquartered in Villaz-Saint-Pierre, Switzerland, with an additional North American office in Minnesota.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on regenHU.